foxo4-dri senolytic 2023 2024 study Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis CHK2-USP37 axis stabilizes FOXO4 to

The trial did not resume enrollment Preclinical cardiac evidence: Animal models of myocardial infarction demonstrated RGN-352 reduced scar volume, improved cardiac function, and increased survival, forming the basis for the clinical program (PMID: 25015963) RGN-259 (Thymosin Beta-4 Ophthalmic Solution for Dry Eye): ARISE-1 and ARISE-2 Phase 3 trials: Evaluated Thymosin Beta-4 eye drops for dry eye disease with mixed results some endpoints showed improvement in signs of dry eye, but the pre-specified co-primary endpoints were not met, though some secondary endpoints showed statistically significant improvements in certain signs of dry eye (PMID: 23050815) These ophthalmic trials represent the most advanced clinical testing of any Thymosin Beta-4 formulation Independent Pilot Study (China, 2016): A small pilot study randomized 10 STEMI (heart attack) patients into two groups: 5 receiving Thymosin Beta-4-pretreated endothelial progenitor cells (EPCs) and 5 receiving untreated EPCs After 6 months, the Thymosin Beta-4-pretreated group showed trends toward improved cardiac function markers including ejection fraction and exercise capacity, though the very small sample size (n=5 per group) means these results should be considered hypothesis-generating only, not evidence of efficacy (PMID: 27288307) No severe complications were reported in either group during follow-up Important: This study used Thymosin Beta-4 as a cell pretreatment agent ex vivo (EPCs exposed to TB4 before transplantation), not as a directly administered drug

The California Horse Racing Board (CHRB) told the Paulick Report this week that the Board of Stewards at Santa Anita was given information by HISA/HIWU, which led to the determination that Barocios horses had an elevated risk for welfare and integrity concerns

Early data from Alzheimer's trials has generated genuine excitement, proposing that GLP-1 signaling may modulate the neuroinflammation that drives cognitive decline

Awards 2006 Perfect Record Safety Award for Hours Worked on Host Sites by Austin Safety Training Consortium 2007 Safety Through Exemplary Performance (STEP) Silver Award 2008 Safety Through Exemplary Performance (STEP) Silver Award Safety Through Exemplary Performance (STEP) Gold Award 2009 Excellence in Construction in $25-$100 million category by TEXO National EAGLE Award in $25-$100 million category by Associated Builders and Contractors Safety Through Exemplary Performance (STEP) Silver Award Safety Through Exemplary Performance (STEP) Gold Award Related Projects NIH Rocky Mountain Laboratory Comparative Medicine Center Building B Learn More Healthcare project NIH Surgery, Radiology & Laboratory Medicine Building Learn More Healthcare project University of Washington Critical Care Projects Learn More Healthcare project UCHealth Memorial Hospital Central 5th and 6th Floor 40-Bed Buildout Learn More Healthcare project INOVA Center for Personalized Health Central Facilities Building Renovation & Air Handling Unit Replacement Learn More Healthcare project Kaiser Permanente Springfield Replacement Medical Office Building Learn More Healthcare project

The injury procedure involved laminectomy (level L2-L3) and a 60-s compression (neurosurgical piston (6066 g) of the exposed dural sac of the sacrocaudal spinal cord)